Sign In
Buy AGRX
$1.51
+0 (+0%)
At Close: Nov 25, 2024
Why Agile Therapeutics Stock Is Jumping Today
04:07pm, Monday, 04'th May 2020
What happened Agile Therapeutics (NASDAQ: AGRX), a small-cap women's healthcare company, is starting the week off on the right foot. Specifically, the drugmaker's shares are up by 11.2% on extremely h
20 Healthcare Stocks Moving In Monday's Pre-Market Session
11:44am, Monday, 04'th May 2020The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace
12:00am, Sunday, 03'rd May 2020
Biotech stocks started last week on a strong note but the upward momentum slowed through the week. The week saw a slew of earnings from big pharma names, including Merck...
Agile Therapeutics: Billion Dollar Buy-Out Is On The Horizon
12:45pm, Friday, 01'st May 2020
Agile Therapeutics is currently trading substantially below its fair value of $6.36/shr on a stand-alone basis. Agile's leading drug, Twirla, is much more valua
Agile Therapeutics to Host First Quarter 2020 Financial Results and Business Update Conference Call on Tuesday, May 5, 2020
11:30am, Thursday, 23'rd Apr 2020
Agile Therapeutics, Inc. (AGRX), a forward-thinking women’s healthcare company, today announced it will report first quarter 2020 financial results after the market close on Tuesday, May 5, 2020. F
Spectrum Pharmaceuticals Appoints Seth H.Z. Fischer to Board of Directors
11:00am, Thursday, 23'rd Apr 2020
Spectrum Pharmaceuticals Appoints Seth H.Z. Fischer to Board of Directors
Agile Therapeutics nominates Sharon Barbari to board of directors AGRX;CYTK;GILD
12:47pm, Wednesday, 22'nd Apr 2020
Agile Therapeutics nominates Sharon Barbari to board of directors AGRX CYTK GILD
Agile Therapeutics Announces Changes to its Board of Directors
12:00pm, Wednesday, 22'nd Apr 2020
Agile Therapeutics, Inc. (AGRX), a forward-thinking women’s healthcare company, today announced that the company has nominated Sharon Barbari for election as a class III director to replace Abhijeet
Agile Therapeutics (AGRX) Flat As Market Sinks: What You Should Know
09:50pm, Wednesday, 01'st Apr 2020
Agile Therapeutics (AGRX) closed at $1.86 in the latest trading session, marking no change from the prior day.
Agile Therapeutics (AGRX) Flat As Market Sinks: What You Should Know
12:00am, Wednesday, 01'st Apr 2020Week 14 MDA Breakout Forecast: Short-Term Picks To Give You An Edge
07:37pm, Saturday, 28'th Mar 2020
Two sample Breakout Stocks for Week 14 with better than 10% short-term upside potential. The MDA Breakout portfolio is up +11.10% YTD compared to the S&P 500 -2
RBC Capital Keeps a Buy Rating on Agile Therapeutics (AGRX)
02:47pm, Wednesday, 25'th Mar 2020
In a report released today, Randall Stanicky from RBC Capital reiterated a Buy rating on Agile Therapeutics (AGRX), with a price target of $8.00. The
